Tug of War Continues<br />By Rev Shark<br />RealMoney.com Contributor<br />6/22/2009 8:51 AM EDT<br /><br /> It is not the strongest of the species that survive, nor the most intelligent, but the one most responsive to change.<br /> -- Charles Darwin<br /><br />Last week the market underwent its second mild correction since the rally began back in March. The last correction was in mid-May, and within a couple of weeks the market had righted itself and went on to break to a new recent high.<br /><br />The current correction, which started last Monday, has so far been equally limited. After two days of selling, we found some support and have had a minor bounce; the action looked much better on Friday as some of the momentum returned to recent favorites that had been struggling.<br /><br />But is the current pullback like the one in May -- quickly forgotten as buyers jump in -- or are we finally seeing signs that the rally off the March low is stumbling and ready for a more protracted pullback?<br /><br />Let's examine the bullish case first. The major indices still have yet to do anything really negative. The S&P 500 has pulled back to some underlying support near its 200- and 50-day moving averages but has not taken out the May lows. While we have lost some upside momentum, the indices have not cracked technically.<br /><br />Another positive for the bulls here is that the second quarter is winding down, and money managers will be looking to add some performance points to their retails. The dips in this market have been extremely shallow for so long because there are so many underinvested longs. They have not had an opportunity to buy any notable weakness, and with the end of the quarter out there, they are very likely to maintain some underlying bids so they can try to catch some opportunities before the end of June.<br /><br />The market has also seen some healthy momentum trading. We have consistently had some very hot pockets of trading for a while now. The names have shifted around in groups like solar energy, low-priced biotechnology and small-cap China, but traders are hunting for action and they tend to get active again very fast, as we saw Friday when quite a few of the fast-moving, high-beta, stocks came back to life.<br /><br />Overall, the bulls still look OK, although they are stumbling a bit and are showing some signs of stress ... which brings us to the bear case for this market. The primary argument for the bears right now is that the market has gone too far, too fast. While things may be "less bad" and the pace of decline is slowing, we don't have any signs of robust growth either. The market has been acting like a "V"-shaped economic recovery is occurring, but no one really seems believe that it will be very quick or easy.<br /><br />The market has already fooled a lot of folks by staying stronger much longer than they anticipated. That is the nature of momentum, but this move also has many of the hallmarks of a typical bear-market rally. You simply aren't going to find companies that are seeing great revenue and EPS growth. You have cost-cutting and low expectations as drivers on the fundamental side, which is fine, but at some point, real growth is needed to keep the market running.<br /><br />So we have a market that hasn't done too much wrong but that is showing some stress fractures. The end of the quarter may help to hold us up, but the fundamental improvement of the economy is being aggressively priced in, and you have to wonder how much more we can go on that basis when the phrase "green shoots" is getting to be a joke.<br /><br />We have a little softness to start the day as European stocks saw pullbacks mainly due to weakness in commodities, and the World Bank forecasts that GDP in Europe, Japan and the U.S. will contract by 4.2% this year. <br />---------------------------------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: MRVL+3.2%... M&A news: SUAI +48.7% (light volume; Tower Group to acquire Specialty Underwriters' Alliance for $6.72 in Tower common stock), AAUK +7.1% (Xstrata seeks merger with Anglo American to cut costs - WSJ)... Other news: MEDX +12.1% (Patients with inoperable prostate disease recover after single dose of drug - The Independent), BCON +8.0% (agrees to accelerate funding of up to $14 million from Seaside 88), EMKR +6.0% (awarded a $5.7 mln Contract From the Air Force Research Laboratory for development of high-efficiency photovoltaic solar cells), LSI +5.3% (light volume; mentioned positively in Barron's), CLDA +1.9% (announces approval of Generic Name Vilazodone, first in a new class of experimental treatments for depression).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: WAG -5.9%, FMCN-1.6%... Select financial names showing weakness: DB -5.8%, IRE -5.2%, SLM -4.7%, ING -3.8%, AZ -3.5%, AXA -3.1%, UBS -2.7%, WFC -1.9%, CS -1.8%, BAC -1.7%, C -1.6%, RBS -1.1%... Select oil/gas names trading lower: BJS -7.2%, STO -4.4%, HAL -2.9%, TOT -2.5%, PBR -2.5%, E -2.1%, COP -2.0%, APA -1.8%, OXY -1.6%... Select metals/mining names showing weakness: RTP -5.7%, HMY -4.7%, MT -3.9%, BBL -2.9%, ABX -2.9%, SLV -2.6%, AUY -2.4%, GDX -2.2%, AU -2.1%, GOLD -2.1%, BHP -1.6%, GLD -1.1%... Select shipping names ticking lower: FRO -5.1%, EGLE -2.9%, EXM -2.3%, DRYS -2.3%, DSX -2.2%... Other news: LNET -9.5% (announces proposed private offering of $50 mln of convertible preferred stock), RGR -7.7% (Smith & Wesson and Sturm, Ruger mentioned negatively in Barron's), SLM -4.7% (still checking), SWHC -3.8% (Smith & Wesson and Sturm, Ruger mentioned negatively in Barron's), RIMM -2.7% (still checking), SI -2.3% (Siemens CEO says it's realistic that global econ approaching low - DJ; expects around $21 billion in new orders from Stimulus Programs worldwide), PRX -1.9% (filed for a $150 mln mixed shelf offering), CVS -1.1% (down in sympathy with WAG)... Analyst comments: ALU -5.1% (downgraded to Underperform at BofA/Merrill), NIHD -3.7% (downgraded to Neutral from Buy at Goldman- Reuters).